Thomas Catinazzo - 28 Jul 2022 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Financial Officer
Signature
/s/ Brian Adams, as attorney-in-fact
Issuer symbol
RLAY
Transactions as of
28 Jul 2022
Net transactions value
-$15,605
Form type
4
Filing time
29 Jul 2022, 16:53:47 UTC
Previous filing
28 Jun 2022
Next filing
08 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $15,605 -734 -1.4% $21.26 52,218 28 Jul 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units ("RSUs") on July 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 45,273 shares underlying RSUs.